Skip to main content
OpenTrials

Clinical trial condition

Generalized Myasthenia Gravis

Explore clinical trials studying Generalized Myasthenia Gravis. Study availability and eligibility vary by location and protocol.

51 public trials 20 recruiting studies
Refine in advanced search Browse all conditions

Generalized Myasthenia Gravis trial results

Completed

A Phase 3, Open-label, Crossover Study to Evaluate Self-administration of Rozanolixizumab by Study Participants With Generalized Myasthenia Gravis (gMG)

NCT05681715

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
Locations
  • Mg0020 50092 Orange, California, United States
  • Mg0020 50099 San Francisco, California, United States
  • Mg0020 50561 Lexington, Kentucky, United States
  • Mg0020 50090 Winston-Salem, North Carolina, United States
View all 27 locations
View Trial Details
Completed

An Open-label Study to Evaluate the Safety, Tolerability, and Efficacy of Subcutaneous Zilucoplan in Participants With Generalized Myasthenia Gravis Who Were Previously Receiving Intravenous Complement Component 5 Inhibitors

NCT05514873

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
Locations
  • Mg0017 50564 Scottsdale, Arizona, United States
  • Mg0017 50559 Los Angeles, California, United States
  • Mg0017 50593 Rancho Mirage, California, United States
  • Mg0017 50099 San Francisco, California, United States
View Trial Details
Completed

Safety and Efficacy Study of Ravulizumab in Adults With Generalized Myasthenia Gravis

NCT03920293

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
Locations
  • Research Site Phoenix, Arizona, United States
  • Research Site Phoenix, Arizona, United States
  • Research Site Phoenix, Arizona, United States
  • Research Site Irvine, California, United States
View all 106 locations
View Trial Details
Completed

A Safety and Tolerability Study of ARGX-113 in Patients With Myasthenia Gravis Who Have Generalized Muscle Weakness.

NCT03770403

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
Locations
  • Investigator Site 42 Carlsbad, California, United States
  • Investigator Site 8 Los Angeles, California, United States
  • Investigator Site 33 Orange, California, United States
  • Investigator Site 21 Palo Alto, California, United States
View all 52 locations
View Trial Details
Completed

A Study to Evaluate the Safety, Tolerability, Efficacy, Pharmacokinetics and Pharmacodynamics of M281 Administered to Adults With Generalized Myasthenia Gravis

NCT03772587

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
Locations
  • Momenta Investigational Site Phoenix, Arizona, United States
  • Momenta Investigational Site Tucson, Arizona, United States
  • Momenta Investigational Site Los Angeles, California, United States
  • Momenta Investigational Site Orange, California, United States
View all 61 locations
View Trial Details
Completed

Evaluating the Pharmacodynamic Noninferiority of Efgartigimod PH20 SC Administered Subcutaneously as Compared to Efgartigimod Administered Intravenously in Patients With Generalized Myasthenia Gravis

NCT04735432

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
Locations
  • Investigator site 2 - US0010032 Carlsbad, California, United States
  • Investigator Site 41 - US0010004 Orange, California, United States
  • Investigator site 2 - US0010108 Boca Raton, Florida, United States
  • Investigator site 1 - US0010110 Port Charlotte, Florida, United States
View all 47 locations
View Trial Details
Completed

Safety and Efficacy Study of RA101495 in Subjects With Generalized Myasthenia Gravis

NCT03315130

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
Locations
  • Diagnostic and Medical Clinic - Mobile Mobile, Alabama, United States
  • The Research Center of Southern California Carlsbad, California, United States
  • UCLA Medical Center Los Angeles, California, United States
  • University of California Irvine Health ALS and Neuromuscular Center Orange, California, United States
View all 30 locations
View Trial Details
Completed

An Efficacy and Safety Study of ARGX-113 in Patients With Myasthenia Gravis Who Have Generalized Muscle Weakness

NCT03669588

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
Locations
  • Investigator Site 29 Phoenix, Arizona, United States
  • Investigator Site 66 Carlsbad, California, United States
  • Investigator Site 5 Los Angeles, California, United States
  • Investigator Site 49 Los Angeles, California, United States
View all 66 locations
View Trial Details

Related conditions